Login
Companies $RADX
$0.79 +$0.02 (2.58%) After hours
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd

radiopharmtheranostics.com

How Do They Make Money?

The company earns revenue from customer contracts over time, including a development-services contract under which Lantheus covers clinical development costs and may pay milestone amounts.

FY2026 revenue

Who Are Their Customers?

Lantheus engages Radiopharm under a strategic development-services contract to advance radiopharmaceuticals in Australia.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support